Prospective Evaluation of Pharmacogenomics and Metabolite Measurements upon Azathioprine Therapy in Inflammatory Bowel Disease: An Observational Study

Up to approximately 40% to 50% of patients discontinue thiopurine therapy during the course of inflammatory bowel disease (IBD). We investigated the role of the metabolite thiopurine in IBD treatment. This was a prospective study. IBD patients receiving azathioprine (AZA) were prospectively included...

Descripción completa

Detalles Bibliográficos
Autores principales: Fangbin, Zhang, Xiang, Gao, Liang, Ding, Hui, Liu, Xueding, Wang, Baili, Chen, Huichang, Bi, Yinglian, Xiao, Peng, Cheng, Lizi, Zhao, Yanjun, Chu, Feng, Xu, Minhu, Chen, Min, Huang, Pinjin, Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2016
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839824/
https://www.ncbi.nlm.nih.gov/pubmed/27082580
http://dx.doi.org/10.1097/MD.0000000000003326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839824/
https://www.ncbi.nlm.nih.gov/pubmed/27082580
http://dx.doi.org/10.1097/MD.0000000000003326

Ejemplares similares